Treatment of attention-deficit/hyperactivity disorder

3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.

Saved in:
Bibliographic Details
Main Authors Bain, Earle E, Abi-Saab, Walid M, Dutta, Sandeep, Garimella, Tushar S, Awni, Walid M, Saltarelli, Mario D
Format Patent
LanguageEnglish
Published 17.07.2012
Online AccessGet full text

Cover

Abstract 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.
AbstractList 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.
Author Abi-Saab, Walid M
Bain, Earle E
Dutta, Sandeep
Awni, Walid M
Saltarelli, Mario D
Garimella, Tushar S
Author_xml – sequence: 1
  givenname: Earle E
  surname: Bain
  fullname: Bain, Earle E
– sequence: 2
  givenname: Walid M
  surname: Abi-Saab
  fullname: Abi-Saab, Walid M
– sequence: 3
  givenname: Sandeep
  surname: Dutta
  fullname: Dutta, Sandeep
– sequence: 4
  givenname: Tushar S
  surname: Garimella
  fullname: Garimella, Tushar S
– sequence: 5
  givenname: Walid M
  surname: Awni
  fullname: Awni, Walid M
– sequence: 6
  givenname: Mario D
  surname: Saltarelli
  fullname: Saltarelli, Mario D
BookMark eNrjYmDJy89L5WQwDSlKTSzJTc0rUchPU0gsKQGyMvPzdFNS0zKTM0v0MyoLUosSk0syyzJLKhVSMovzi1JSi3gYWNMSc4pTeaE0N4OCm2uIs4duaXFBIsiI4vj0okQQZWBhBATmFsZEKAEAj2Awqg
ContentType Patent
CorporateAuthor Abbott Laboratories
CorporateAuthor_xml – name: Abbott Laboratories
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 08222278
GroupedDBID EFH
ID FETCH-uspatents_grants_082222783
IEDL.DBID EFH
IngestDate Sun Mar 05 22:31:07 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_082222783
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8222278
ParticipantIDs uspatents_grants_08222278
PatentNumber 8222278
PublicationCentury 2000
PublicationDate 20120717
PublicationDateYYYYMMDD 2012-07-17
PublicationDate_xml – month: 07
  year: 2012
  text: 20120717
  day: 17
PublicationDecade 2010
PublicationYear 2012
References Buckley et al. (2004/0242641) 20041200
Buckley et al. (7354937) 20080400
(WO2004/106342) 20041200
Wayne et al. (7351833) 20080400
Wayne et al. (7498444) 20090300
Buckley et al. (7538226) 20090500
International Search Report dated Sep. 24, 2009.
Schrimpf et al. (6809105) 20041000
Buckley et al. (2004/0242644) 20041200
References_xml – year: 20080400
  ident: 7351833
  contributor:
    fullname: Wayne et al.
– year: 20090500
  ident: 7538226
  contributor:
    fullname: Buckley et al.
– year: 20041200
  ident: 2004/0242641
  contributor:
    fullname: Buckley et al.
– year: 20041200
  ident: WO2004/106342
– year: 20041200
  ident: 2004/0242644
  contributor:
    fullname: Buckley et al.
– year: 20080400
  ident: 7354937
  contributor:
    fullname: Buckley et al.
– year: 20090300
  ident: 7498444
  contributor:
    fullname: Wayne et al.
– year: 20041000
  ident: 6809105
  contributor:
    fullname: Schrimpf et al.
Score 2.8603861
Snippet 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated...
SourceID uspatents
SourceType Open Access Repository
Title Treatment of attention-deficit/hyperactivity disorder
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8222278
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NSwMxEB3aIqgnpYr1ixx6ja3Nptk9S5elUOmhQm9l86UH3S3dlP59Z9JavOg1gcmQkLx58OYFoG8zI4Qxmms_UjzJtOCldyXXVrvUJtL52OU6ex0Xb8l0KZctKI69MF94jfgac2mets061FFcic_7_uD53vyZPAIrch_YVZ91aefWDwjoRiptQzsdkrRvkhfncIohsGSrQvMLNPILOJnH0UtouaoLcvGj6Wa1Z2RrGYWG3DoycQiDD2SEsWWJfnNg9uCKeQUsnyxeCn5cY_W-Ie3KanjIRVxDBzm8uwEmtEJmoIwtU5Moqmti4aOk1dnYZ7IHvT_D3P4zdwdniOBRP_qs7qETNlv3gCgZ9GPcgm9uEnRy
link.rule.ids 230,309,783,805,888,64375
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwEB2VglhOIECU1QeuplDHdXIujcJW5VCk3qJ4gwNNqsYVv4_HXcQFrrY0Htkavxn5zTPArU4UY0pJKm1P0CiRjJbWlFRqaWIdcWNDl-vbqJ-9R88TPmlBtumFmfowojPvS3O3aGauDuRKf70vD54uxZ9RI7BC9YHv6qsuda5tF4GuJ-It2ManKCT3DdPsAPa8EZ-0Va75BRvpIezkYfQIWqY6Bj5es7pJbQkKWwaqIdUGZRxc99PXhKFpCf9zIHqli3kCJB2OBxndrFF8zJG9UtyvvGGn0PZVvDkDwqTwtYFQuoxVJDCzCamP4FomfZvwDnT-NHP-z9wN7OaPafH6NHq5gH0P54FM-iAuoe3mC3PlIdPJ67AbP1EPd24
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Treatment+of+attention-deficit%2Fhyperactivity+disorder&rft.inventor=Bain%2C+Earle+E&rft.inventor=Abi-Saab%2C+Walid+M&rft.inventor=Dutta%2C+Sandeep&rft.inventor=Garimella%2C+Tushar+S&rft.inventor=Awni%2C+Walid+M&rft.inventor=Saltarelli%2C+Mario+D&rft.number=8222278&rft.date=2012-07-17&rft.externalDBID=n%2Fa&rft.externalDocID=08222278